|
Volumn 118, Issue 1, 2006, Pages 268-270
|
Controversies following the report on transplantation of cephalocervical skin flap [8]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DACLIZUMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
CANCER SURGERY;
CANCER SURVIVAL;
COMPOSITE GRAFT;
COMPOSITE SKIN GRAFT;
DISEASE SEVERITY;
FOLLOW UP;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LYMPH NODE METASTASIS;
MEDICAL ETHICS;
MEDICOLEGAL ASPECT;
MELANOMA;
PLASTIC SURGERY;
POSTOPERATIVE CARE;
PREOPERATIVE PERIOD;
PRIORITY JOURNAL;
SKIN ALLOGRAFT;
SKIN DEFECT;
SKIN FLAP;
SKIN TRANSPLANTATION;
SURVIVAL RATE;
SURVIVAL TIME;
TUMOR VOLUME;
AGED;
ALLOTRANSPLANTATION;
EAR TUMOR;
EXTERNAL EAR;
FEMALE;
METHODOLOGY;
NOTE;
PATIENT SELECTION;
SCALP;
SKIN TUMOR;
TRANSPLANTATION;
TUMOR RECURRENCE;
AGED;
EAR NEOPLASMS;
EAR, EXTERNAL;
FEMALE;
HUMANS;
MELANOMA;
NEOPLASM RECURRENCE, LOCAL;
PATIENT SELECTION;
RECONSTRUCTIVE SURGICAL PROCEDURES;
SCALP;
SKIN NEOPLASMS;
SURGICAL FLAPS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 33746836615
PISSN: 00321052
EISSN: None
Source Type: Journal
DOI: 10.1097/01.prs.0000222222.18263.0f Document Type: Letter |
Times cited : (9)
|
References (10)
|